Closer examination of co-mutation patterns for ERBB2 TMD mutations in NSCLC revealed divergent co-occurrence or mutual exclusivity with EGFR or ERBB3 TMD mutations based on the specific ERBB2 TMD allele. This evidence concerns the gene EGFR and non-small cell lung carcinoma.